RTX and Other Defense Stocks Have a Midterm Headache

Dow Jones11-04

Voters resoundingly rejected President Donald Trump's war in Iran on Tuesday, as the Democrats took control of the Senate and the House.

The blue wave was boosting the broader market but dragging down shares of defense contractors, which have been boosted this year by the prospect of a massive uptick in military spending.

RTX fell 2.8% and Lockheed Martin dropped 3.7% ahead of the opening bell. General Dynamics, Honeywell, L3Harris, and Northrop Grumman were also sliding.

Trump in April requested a one-off increase in military spending to $1.5 trillion, to allow the Pentagon to pour money into drones, AI, and space technology while also covering some costs from the war in Iran.

But the Democratic sweep could scuttle the White House's hopes of a massive uptick in military funding.

Barron's argued on Tuesday that the Democrats could use defense as leverage against Trump. The government's current funding measures expire in December, which could give the House and the Senate time to negotiate military spending down.

That would be a blow for the likes of RTX and Lockheed, which generate tens of billions of dollars a year from their contracts with the U.S. government.

Trump appeared to acknowledge that the war in the Middle East contributed to the Republicans' poor performance on Tuesday.

"Iran was a piece of it," he told The Wall Street Journal when asked if the war was a factor in Tuesday's midterm losses.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment